Abstract

Chronic renal failure is associated with many neurological complications. Due to accumulation of uremic neurotoxins axonal degeneration with its secondary demyelination occurs, which results in development of polineuropathy in 60-100% of patients with chronic renal failure. One of the most severe peripheral neuropathy is optic neuropathy. It is associated with visual deterioration and reduction in quality of life. Symptoms of the optic neuropathy may appear either before or after dialysis therapy. They often worsen after renal transplant, probably due to immunosuppressive regimen. Early diagnostics of the optic neuropathy became possible by using visual evoked potentials (VEP). This reliable, sensitive and noninvasive technique provides a direct measure of subclinical impairment of visual pathways. Among hemodialysed or immunosupressed patients one can observe abnormal VEP parameters – especially prolonged latency of the P100 component, less often fluctuation of its amplitude. These alterations are pronounced even if clinical examination reveals no abnormalities. This review presents a summary of current use of visual evoked potentials in monitoring of patients with chronic renal failure.

References

• 1. Abramson J.L., Jurkovitz C.T., Vaccarino V., Weintraub W.S., McClellan W.: Chronic kidney disease, anemia, and incident stroke in a middle‑aged, community‑based population: the ARIC Study. Kidney Int., 2003; 64: 610‑615
  Google Scholar
• 2. Aminoff M.J.: Neurology and general medicine. W: Raskin N.H. (red.), Philadelphia: Churchill Livingstone;1995, 303‑319
  Google Scholar
• 3. Apsner R., Schulenburg A., Steinhoff N., Keil F., Janata K., Kalhs P., Greinix H.: Cyclosporin A‑induced ocular flutter after marrow transplantation. Bone Marrow Transplant., 1997; 20: 255‑256
  Google Scholar
• 4. Arieff A.I.: Neurological complications of uremia. Philadelphia, W.B. Saunders, 2nd ed., Kidney, 1981; 2306‑2343
  Google Scholar
• 5. Arnold R., Pussell B.A., Pianta T.J., Lin C.S., Kiernan M.C., Krishnan A.V.: Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. Am. J. Transplant., 2013; 13: 2426‑2432
  Google Scholar
• 6. Asbury A.K.: Uremic neuropathy. Peripheral neuropathy. W.B. Saunders Company. Philadelphia, 1975; 1: 982‑992
  Google Scholar
• 7. Avery R., Jabs D.A., Wingard J.R., Vogelsang G., Saral R., Santos G.: Optic disc edema after bone marrow transplantation. Possible role of cyclosporine toxicity. Ophthalmology, 1991; 98: 1294‑1301
  Google Scholar
• 8. Bechstein W.O.: Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl. Int., 2000; 13: 313‑326
  Google Scholar
• 9. Bloom I.T., Bentley F.R., Garrison R.N.: Acute cyclosporine‑induced renal vasoconstriction is mediated by endothelin‑1. Surgery, 1993; 114: 480‑487
  Google Scholar
• 10. Brazis P.W., Spivey J.R., Bolling J.P., Steers J.L.: A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am. J. Ophthalmol., 2000; 129: 536‑538
  Google Scholar
• 11. Brezny I., Gaziova M.: Late high voltage EEG responses to slowly repeated flashes. Electroencephalogr. Clin. Neurophysiol., 1964; 16: 383‑387
  Google Scholar
• 12. Bronster D.J., Emre S., Mor E., Sheiner P., Miller C.M., Schwartz M.E.: Neurologic complications of orthotopic liver transplantation. Mt. Sinai J. Med., 1994; 61: 63‑69
  Google Scholar
• 13. Brouns R., De Deyn P.P.: Neurological complications in renal failure: a review. Clin. Neurol. Neurosurg., 2004; 107: 1‑16
  Google Scholar
• 14. Brown J.J., Sufit R.L., Sollinger H.W.: Visual evoked potential changes following renal transplantation. Electroencephalogr. Clin. Neurophysiol., 1987; 66: 101‑107
  Google Scholar
• 15. Buoncristiani U., Alberti A., Gubbiotti G., Mazzotta G., Gallai V., Quintaliani G., Gaburri M.: Better preservation of cognitive faculty in continuous ambulatory peritoneal dialysis. Perit. Dial. Int., 1993; 13 (Suppl. 2): S202‑S205
  Google Scholar
• 16. Burn D.J., Bates D.: Neurology and the kidney. J. Neurol. Neurosurg. Psychiatry, 1998; 65: 810‑821
  Google Scholar
• 17. Cantor F.K., Ilbag F.: Facilitation of photic response by focal lesions. Electroencephalogr. Clin. Neurophysiol., 1973; 34: 77‑79
  Google Scholar
• 18. Cohen S.N., Syndulko K., Rever B., Kraut J., Coburn J., Tourtellotte W.W.: Visual evoked potentials and long latency event‑related potentials in chronic renal failure. Neurology, 1983; 33: 1219‑1222
  Google Scholar
• 19. Coley S.C., Porter D.A., Calamante F., Chong W.K., Connelly A.: Quantitative MR diffusion mapping and cyclosporine‑induced neurotoxicity. AJNR Am. J. Neuroradiol., 1999; 20: 1507‑1510
  Google Scholar
• 20. Crighel E., Botez M.I.: Photic evoked potentials in man in lesions of the occipital lobes. Comments on some electrographic phenomena pointing to the existence of a vicarious function. Brain, 1966; 89: 311‑316
  Google Scholar
• 21. Cueoglu S., Osma U., Alkaya Z., Sari Y., Meric F., Topcu I., Yilmaz M.E. : The comparison of dialysis types’ effects on hearing acuity and baer findings in patients with chronic renal failure. Nagoya Med. J., 1999, 43: 27‑33
  Google Scholar
• 22. Demirbilek V., Calişkan S., Cokar O., Angay A., Sever L., Dervent A.: A study on visual evoked responses in children with chronic renal failure. Neurophysiol. Clin., 2005; 35: 135‑141
  Google Scholar
• 23. Derici U., Nazliel B., Irkec C., Sindel S., Arinsoy T., Bali M.: Effect of haemodialysis on visual‑evoked potential parameters. Nephrology, 2003; 8: 11‑15
  Google Scholar
• 24. Ducati A., Cattarelli D., Cenzato M., Landi A., Edefonti A., Capitanio L., Pavani M., Villani R.: Changes in visual evoked potentials in children on chronic dialysis treatment. Childs Nerv. Syst., 1985; 1: 282‑287
  Google Scholar
• 25. Dumitru D., Amato A.A., Zwarts M.J.: Nerve conduction studies. Electrodiagnostic. Med. Philadelphia: Hanley & Belfus. 2002; 159‑223
  Google Scholar
• 26. Ejma M., Szymańska G., Podemski R., Klinger M., Piechocki D., Weyde W.: Analysis of bioelectrical cerebral function based on visual and brain stem auditory evoked potentials in patients with chronic renal failure. Med. Sci. Monit., 1999; 5: MT318‑MT323
  Google Scholar
• 27. el Aklouk I., Basić Kes V., Basić‑Jukić N., Brunetta B., Kes P.: Uremic polyneuropathy. Acta Med. Croatica, 2004; 58: 59‑61
  Google Scholar
• 28. Erer B., Polchi P., Lucarelli G., Angelucci E., Baronciani D., Galimberti M., Giardini C., Gaziev D., Maiello A.: CsA‑associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplant., 1996; 18: 157‑162
  Google Scholar
• 29. Esterl R.M. Jr., Gupta N., Garvin P.J.: Permanent blindness after cyclosporine neurotoxicity in a kidney‑pancreas transplant recipient. Clin. Neuropharmacol., 1996; 19: 259‑266
  Google Scholar
• 30. Ethier A.A., Lippé S., Mérouani A., Lassonde M., Saint‑Amour D.: Reversible visual evoked potential abnormalities in uremic children. Pediatr. Neurol., 2012; 46: 390‑392
  Google Scholar
• 31. Fiorani L., Bandini G., D’Alessandro R., Rosti G.: Cyclosporin A neurotoxicity after allogeneic bone marrow transplantation. Bone Marrow Transplant., 1994; 14: 175‑176
  Google Scholar
• 32. Galassi G., Ferrari S., Cobelli M., Rizzuto N.: Neuromuscular complications of kidney diseases. Nephrol. Dial. Transplant., 1998; 13 (Suppl. 7): 41‑47
  Google Scholar
• 33. Ghalie R., Fitzsimmons W.E., Bennett D., Kaizer H.: Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant., 1990; 6: 147‑149
  Google Scholar
• 34. Giannotta S.L., Delaney‑Harder J.: Neurologic complications of renal failure, dialysis, and renal transplantation. W: Wilson S.E. (red.), Vascular access surgery. Chicago: Year Book Medical Publishers, 1979: 321‑335
  Google Scholar
• 35. Giblin D.R.: Somatosensory evoked potentials in healthy subjects and in patients with lesions of the nervous system. Ann. NY Acad. Sci., 1964; 112: 93‑142
  Google Scholar
• 36. Gijtenbeek J.M., van den Bent M.J., Vecht C.J.: Cyclosporine neurotoxicity: a review. J. Neurol., 1999; 246: 339‑346
  Google Scholar
• 37. Gopal A.K., Thorning D.R., Back A.L.: Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings. Bone Marrow Transplant., 1999: 23: 191‑193
  Google Scholar
• 38. Hamel B., Bourne J.R., Ward J.W., Teschan P.E.: Transient and steady‑state visually evoked cortical potentials in renal disease. Electroencephalogr. Clin. Neurophysiol., 1976; 40
  Google Scholar
• 39. Hamel B., Bourne J.R., Ward J.W., Teschan P.E.: Visually evoked cortical potentials in renal failure: transient potentials. Electroencephalogr. Clin. Neurophysiol., 1978; 44: 606‑616
  Google Scholar
• 40. Ho D.T., Rodig N.M., Kim H.B., Lidov H.G., Shapiro F.D., Raju G.P., Kang P.B.: Rapid reversal of uremic neuropathy following renal transplantation in an adolescent. Pediatr. Transplant., 2012; 16: E296‑E300
  Google Scholar
• 41. Hosoya K., Tachikawa M.: Roles of organic anion/cation transporters at the blood‑brain and blood‑cerebrospinal fluid barriers involving uremic toxins. Clin. Exp. Nephrol., 2011; 15: 478‑485
  Google Scholar
• 42. Hurkx W., Hulstijn‑Dirkmaat I., Pasman J., Rotteveel J., Visco Y., Schröder C.: Evoked potentials in children with chronic renal failure, treated conservatively or by continuous ambulatory peritoneal dialysis. Pediatr. Nephrol., 1995; 9: 325‑328
  Google Scholar
• 43. Hyman P.R., Kooi K.A.: Visually evoked cortical responses in renal insufficiency. Univ. Mich. Med. Cent. J., 1969; 35: 177‑179
  Google Scholar
• 44. Jahadi‑Hosseini H.R., Rahmani B., Karbassi A., Mehrian M., Medghalchi A.R.: Ocular complications in renal allograft recipients. Transplant. Proc., 2003; 35: 309‑310
  Google Scholar
• 45. Jayamanne D.G., Porter R.: Ocular morbidity following renal transplantation. Nephrol. Dial. Transplant., 1998; 13: 2070‑2073
  Google Scholar
• 46. Jungers P., Chauveau P., Bandin O., Chadefaux B., Aupetit J., Labrunie M., Descamps‑Latscha B., Kamoun P.: Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner. Electrolyte Metab., 1997; 23: 170‑173
  Google Scholar
• 47. Kiernan M.C., Bostock H.: Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain, 2000; 123: 2542‑2551
  Google Scholar
• 48. Kooi K.A., Guevener A.M., Bagchi B.K.: Visual evoked responses in lesions of the higher optic pathways. Neurology, 1965; 15: 841‑854
  Google Scholar
• 49. Krishnan A.V., Kiernan M.C.: Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve, 2007; 35: 273‑290
  Google Scholar
• 50. Krishnan A.V., Lin C.S., Park S.B., Kiernan M.C.: Assessment of nerve excitability in toxic and metabolic neuropathies. J. Peripher. Nerv. Syst., 2008; 13: 7‑26
  Google Scholar
• 51. Król E., Rutkowski B.: Przewlekła choroba nerek – klasyfikacja, epidemiologia i diagnostyka. Forum Nefrol., 2008; 1: 1‑6
  Google Scholar
• 52. Kuba M., Peregrin J., Vít F., Hanusová I., Erben J.: Pattern‑reversal visual evoked potentials in patients with chronic renal insufficiency. Electroencephalogr. Clin. Neurophysiol., 1983; 56: 438‑442
  Google Scholar
• 53. Laaksonen S., Voipio‑Pulkki L., Erkinjuntti M., Asola M., Falck B.: Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J. Intern. Med., 2000; 248: 21‑26
  Google Scholar
• 54. Lacerda G., Krummel T., Hirsch E.: Neurologic presentations of renal diseases. Neurol. Clin., 2010; 28: 45‑59
  Google Scholar
• 55. Lane R.J., Roche S.W., Leung A.A., Greco A., Lange L.S.: Cyclosporin neurotoxicity in cardiac transplant recipients. J. Neurol. Neurosurg. Psychiatry, 1988; 51: 1434‑1437
  Google Scholar
• 56. Lea J.P., Sands J.M., McMahon S.J., Tumlin J.A.: Evidence that the inhibition of Na+/K+‑ATPase activity by FK506 involves calcineurin. Kidney Int., 1994; 46: 647‑652
  Google Scholar
• 57. Lee D.K., Park Y.C.: Alteration of multimodal evoked potentials before and after ranal transplantation in chronic renal failure. J. Korean Neurol. Ass., 1992; 10: 465‑479
  Google Scholar
• 58. Lewis E.G., Dustman R.E., Beck E.C.: Visual and somatosensory evoked potentials characteristics of patients undergoing hemodialysis and kidney transplantation. Electroencephalogr. Clin. Neurophysiol., 1978; 44: 223‑231
  Google Scholar
• 59. Lowitzsch K., Göhring U., Hecking E., Köhler H.: Refractory period, sensory conduction velocity and visual evoked potentials before and after haemodialysis. J. Neurol. Neurosurg. Psychiatry, 1981; 44: 121‑128
  Google Scholar
• 60. Mahoney C.A., Arieff A.I.: Uremic encephalopathies: clinical, biochemical, and experimental features. Am. J. Kidney Dis., 1982; 2: 324‑336
  Google Scholar
• 61. McDiarmid S.V., Busuttil R.W., Ascher N.L., Burdick J., D’Alessandro A.M., Esquivel C., Kalayoglu M., Klein A.S., Marsh J.W., Miller C.M., Schwartz M.E., Shaw B.W., So S. K.: FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation, 1995; 59: 530‑536
  Google Scholar
• 62. McDonald J.W., Goldberg M.P., Gwag B.J., Chi S.I., Choi D.W.: Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann. Neurol., 1996; 40: 750‑758
  Google Scholar
• 63. Mitz M., Prakash A.S., Melvin J., Piering W.: Motor nerve conduction indicators in uremic neuropathy. Arch. Phys. Med. Rehabil., 1980; 61: 45‑48
  Google Scholar
• 64. Mutlu A., Çelik M., Karakullukçu F., Forta H.: Visual evoked potentials in hemodialysis patients. Marmara Med. J., 1999; 12: 122‑125
  Google Scholar
• 65. Ogura T., Makinodan A., Kubo T., Hayashida T., Hirasawa Y.: Electrophysiological course of uraemic neuropathy in haemodialysis patients. Postgrad. Med. J., 2001; 77: 451‑454
  Google Scholar
• 66. O›Riordan J.M., FitzSimon S., O›Connor M., McCann S.R.: Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine. Bone Marrow Transplant., 1994; 13: 101‑104
  Google Scholar
• 67. Pagani C., Bazzi C., Arrigo G., Venturini C.T., D›Amico G.: Evoked potentials (VEPs and BAEPs) in a large cohort of short – and long‑term haemodialysed patients. Nephrol. Dial. Transplant., 1993; 8: 1124‑1128
  Google Scholar
• 68. Palacz O., Lubiński W., Penkala K.: Elektrofizjologiczna diagnostyka kliniczna układu wzrokowego. Oftal Warszawa 2003, wyd.1, ISBN: 83‑912787‑5‑1
  Google Scholar
• 69. Palmer B.F., Toto R.D.: Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am. J. Kidney Dis., 1991; 18: 116‑121
  Google Scholar
• 70. Peppa M., Uribarri J., Cai W., Lu M., Vlassara H.: Glycoxidation and inflammation in renal failure patients. Am. J. Kidney Dis., 2004; 43: 690‑695
  Google Scholar
• 71. Pirsch J.D., Miller J., Deierhoi M.H., Vincenti F., Filo R.S.: A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation, 1997; 63: 977‑983
  Google Scholar
• 72. Ponticelli C., Campise M.R.: Neurological complications in kidney transplant recipients. J Nephrol., 2005; 18: 521‑528
  Google Scholar
• 73. Raskin N.H., Fishman R.A.: Neurologic disorders in renal failure (first of two parts). N. Engl. J. Med., 1976; 294: 143‑148
  Google Scholar
• 74. Reece D.E., Frei‑Lahr D.A., Shepherd J.D., Dorovini‑Zis K., Gascoyne R.D., Graeb D.A., Spinelli J.J., Barnett M.J., Klingemann H.G., Herzig G.P. i wsp.: Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant., 1991; 8: 393‑401
  Google Scholar
• 75. Rizzo P.A., Pierelli F., Pozzessere G., Verardi S., Casciani C.U., Morocutti C.: Pattern visual evoked potentials and brainstem auditory evoked responses in uremic patients. Acta Neurol. Belg., 1982; 82: 72‑79
  Google Scholar
• 76. Romano J., Engel G.L.: Delirium: I. Electroencephalographic data. Arch. Neur. Psych., 1944; 51: 356‑377
  Google Scholar
• 77. Rossini P.M., Pirchio M., Treviso M., Gambi D., Di Paolo B., Albertazzi A.: Checkerboard reversal pattern and flash VEPs in dialysed and non‑dialysed subjects. Electroencephalogr. Clin. Neurophysiol., 1981; 52: 435‑444
  Google Scholar
• 78. Rozeman C.A., Jonkman E.J., Poortvliet D.C., Emmen H.H., de Weerd A.W., van der Maas A.P., Tjandra Y.I., Beermann E.M.: Encephalopathy in patients on continuous ambulatory peritoneal dialysis and patients on chronic haemodialysis. Nephrol. Dial. Transplant., 1992; 7: 1213‑1218
  Google Scholar
• 79. Seymen P., Selamet U., Aytac E., Trabulus S., Seymen H.O.: Evaluation of visual evoked potentials in chronic renal failure patients with different treatment modalities. J. Nephrol., 2010; 23: 705‑710
  Google Scholar
• 80. Skinner J.E., Lindsley D.B.: Enhancement of visual and auditory evoked potentials during blockade of the non‑specific thalamo‑cortical system. Electroencephalogr. Clin. Neurophysiol., 1971; 31: 1‑6
  Google Scholar
• 81. Sloane J.P., Lwin K.Y., Gore M.E., Powles R.L., Smith J.F.: Disturbance of blood‑brain barrier after bone‑marrow transplantation. Lancet, 1985; 2: 280‑281
  Google Scholar
• 82. Talebi M., Sayadnasiri M., Azar S.A.: Effect of renal transplantation on visual evoked potential abnormalities of chronic renal failure. Transplant. Proc., 2010; 42: 3994‑3997
  Google Scholar
• 83. Tan T.C., Robinson P.J.: Mechanisms of calcineurin inhibitor‑induced neurotoxicity. Transplantation Rev., 2006; 20: 49‑60
  Google Scholar
• 84. Teschan P.E.: Electroencephalographic and other neurophysiological abnormalities in uremia. Kidney Int. Suppl., 1975; 2: 210‑216
  Google Scholar
• 85. Teschan P.E., Ginn H.E., Bourne J.R., Ward J.W., Hamel B., Nunnally J.C., Musso M., Vaughn W.K.:
  Google Scholar
• 86. Textor S.C., Taler S.J., Canzanello V.J., Schwartz L., Augustine J.E.: Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl., 2000; 6: 521‑530
  Google Scholar
• 87. Tilki H.E., Akpolat T., Tunali G., Kara A., Onar M.K.: Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Ups. J. Med. Sci., 2004; 109: 43‑48
  Google Scholar
• 88. Truwit C.L., Denaro C.P., Lake J.R., DeMarco T.: MR imaging of reversible cyclosporin A‑induced neurotoxicity. AJNR Am. J. Neuroradiol., 1991; 12: 651‑659
  Google Scholar
• 89. Van Leeuwen M.L., Van Gelder T., Van Gemert H.M., Weimar W.: Cortical blindness due to cyclosporin. Neth. J. Med., 1993; 43: 69‑70
  Google Scholar
• 90. Vázquez de Prada J.A., Martín‑Duran R., García‑Monco C., Calvo J.R., Olalla J.J., González‑Vilchez F., Gutierrez J.A:. Cyclosporine neurotoxicity in heart transplantation. J. Heart Transplant., 1990; 9: 581‑583
  Google Scholar
• 91. Venneti S., Moss H.E., Levin M.H., Vagefi M.R., Brozena S.C., Pruitt A.A., Mourelatos Z., Trojanowski J.Q., Galetta S.L., Balcer L.J.: Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J. Neurol. Sci., 2011; 301: 112‑115
  Google Scholar
• 92. Victor M., Ropper A.: The acquired metabolic disorders of the nervous system. Adams and Victor’s Principles of Neurology, New York: McGraw‑Hill, 2001; 7: 1184‑1190
  Google Scholar
• 93. Walker R.W., Brochstein J.A.: Neurologic complications of immunosuppressive agents. Neurol. Clin., 1988; 6: 261‑278
  Google Scholar
• 94. Walser H., Kriss A., Cunningham K., Halliday A.M., Jones S.J., Taube D.: A multimodal evoked potential assesment of uraemia. W: Nodar Barber (red.), Evoked Potentials II. Boston. 1984: 643‑649
  Google Scholar
• 95. Walter S.H., Bertz H., Gerling J.: Bilateral optic neuropathy after bone marrow transplantation and cyclosporin A therapy. Graefes Arch. Clin. Exp. Ophthalmol., 2000; 238: 472‑476
  Google Scholar
• 96. Weerdt de A., Claeys K.G., De Jonghe P., Ysebaert D., Chapelle T., Roeyen G., Jorens P.G.: Tacrolimus‑related polyneuropathy: case report and review of the literature. Clin. Neurol. Neurosurg., 2008; 110: 291‑294
  Google Scholar
• 97. Wijdicks E.F.: Neurotoxicity of immunosuppressive drugs. Liver Transpl., 2001; 7: 937‑942
  Google Scholar
• 98. Wilson J.R., Conwit R.A., Eidelman B.H., Starzl T., Abu‑Elmagd K.: Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve, 1994; 17: 528‑532
  Google Scholar
• 99. Winkelmayer W.C., Eigner M., Berger O., Grisold W., Leithner C.: Optic neuropathy in uremia: an interdisciplinary emergency. Am. J. Kidney Dis., 2001; 37: E23
  Google Scholar
• 100. Yilmaz S., Gokben S., Arikan C., Calli C., Serdaroglu G.: Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy. Pediatr. Neurol., 2010; 43: 359‑362
  Google Scholar
• 101. Yu Y.L., Cheng I.K., Chang C.M., Bruce I.C., Mok K.Y., Zhong W.Y., Chan Y.W.: A multimodal neurophysiological assessment in terminal renal failure. Acta Neurol. Scand., 1991; 83: 89‑95
  Google Scholar

Full text